IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- NA
Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Signature for Precise Chemosensitivity Prediction in PDAC
- Status
- COMPLETED
- Phase
- N/A
Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
- Status
- RECRUITING
- Phase
- N/A
Cancer Loyalty Card Study 2 (CLOCS-2)
- Status
- RECRUITING
- Phase
- N/A
INSPIRE: a Multi-Cancer Early Detection Study
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
- Status
- RECRUITING
- Phase
- N/A
The Effect of Probiotics ATG-F4 in Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
- Status
- RECRUITING
- Phase
- PHASE2
Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)
- Status
- RECRUITING
- Phase
- PHASE3
Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis
- Status
- RECRUITING
- Phase
- N/A
Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3